Get started
Work

Trends in Anemia Management in Hemodialysis Patients with Cancer

Year: 2020
Type: article
Abstract: Erythropoiesis-stimulating agents (ESAs), intravenous iron, and blood transfusion are used to treat anemia in both end-stage renal disease (ESRD) and cancer. However, anemia treatment patterns have not been described among ESRD patients undergoing hemodialysis with concurrent cancer, especially in the recent era of ESA-related safety concerns.
DOI: 10.17615/pfr4-dw52
Authors: Wheeler, Stephanie B., Butler, Anne M., Olshan, Andrew F., Nielsen, Matthew E., Brookhart, M. Alan, Kshirsagar, Abhijit V.
Language: English
Subfield: Hematology
Field: Medicine
Open Access status: green
Funders: Amgen, Pfizer, Patient-Centered Outcomes Research Institute, National Institutes of Health, Agency for Healthcare Research and Quality, National Institute on Aging, National Cancer Institute, National Institute of Diabetes and Digestive and Kidney Diseases, Eunice Kennedy Shriver National Institute of Child Health and Human Development
Awards: G1271440016, G2343608682, Patterns of use, comparative effectiveness, and safety of rotavirus vaccines, A retrospective cohort study of the safety of testosterone therapy in older men, G6082878906, Propensity Scores and Preventive Drug Use in the Elderly
OpenAlex ID: W4299859660
FWCI:
Cites:
Cited by:
Related to: 10